XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.3

Selected Balance Sheet Information

9 Months Ended

Sep. 30, 2024

Selected Balance Sheet Information

Selected Balance Sheet Information

7. Selected Balance Sheet Information

​

Prepaid expenses and other current assets (in thousands)

​

​	​	​	​	​	​	​
​	​	September 30,		​	December 31,
​		2024			2023
Prepaid manufacturing expenses	​	$	382	​	$	491
Prepaid clinical research organizations	​	​	359	​	​	1,119
Prepaid consulting, subscriptions and other expenses	​	​	286	​	​	180
VAT receivable	​	​	170	​	​	128
Prepaid insurance	​	​	95	​	​	496
​	​	​	​	​	​	​
Total	​	$	1,292	​	$	2,414

​

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services.

​

7. Selected Balance Sheet Information – (continued)

​

Property and equipment, net (in thousands)

​

​	​	​	​	​	​	​
​		September 30,		​	December 31,
​		2024			2023
Computers and office equipment	​	$	715	​	$	902
Other property, plant and equipment	​	​	421	​	​	417
Leasehold improvements	​		94	​		94
Software	​		11	​		11
​	​		1,241	​		1,424
Less: accumulated depreciation and amortization	​		(927)	​		(1,002)
​	​	​	​	​	​	​
Total	​	$	314	​	$	422

​

Accrued expenses (in thousands)

​

​	​	​	​	​	​	​
​		September 30,		​	December 31,
​		2024			2023
Accrued clinical consulting services	​	$	2,358	​	$	1,700
Accrued manufacturing costs	​		820	​		843
Accrued vendor payments	​	​	576	​	​	452
​	​	​	​	​	​	​
Total	​	$	3,754	​	$	2,995

​

Accrued employee benefits (in thousands)

​

​	​	​	​	​	​	​
​		September 30,		​	December 31,
​		2024			2023
Accrued bonus expense	​	$	982	​	$	1,307
Accrued compensation expense	​	​	181	​	​	127
Accrued vacation expense	​		128	​		83
​	​	​	​	​	​	​
Total	​	$	1,291	​	$	1,517

​

X

- References

No definition available.

+ Details

Name:	tovx_BalanceSheetInformationAbstract
Namespace Prefix:	tovx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/210/tableOfContent

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration